Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Partners

Executive Summary

Bristol-Myers Squibb and Lilly on March 18 join Roche, Parke-Davis, Searle and Upjohn as members of the informal group of companies in a program to send representatives to public forums to discuss pharmaceutical industry issues and to fax responses to attacks on the industry ("The Pink Sheet" March 15, T&G-2). Searle Chairman Sheldon Gilgore participated in a March 15 health care reform hearing in Des Moines featuring Hillary Rodham Clinton and appeared the following day on the network TV program CBS This Morning. Assisting Rx Partners under a $2 mil. contract is the Washington, D.C. consulting firm Powell Tate.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS022337

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel